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Background: In 1942, Stout described tumors which derive from Zimmerman’s pericytes and suggested the term
hemangiopericytoma (HPC). These tumors, which are often highly vascularized, pose difficulties in the surgical
management regarding blood loss and complete resection. Therefore, preoperative management seems to be an
essential part in dealing with these issues.
Case presentation: We present a 70-year-old female patient with a large HPC in the pelvis. Preoperative
embolization of the tumor was performed, and 2 weeks after the intervention, we completely resected the tumor
with minimal blood loss.
Conclusion: In which cases do we need preoperative treatment, especially emboliziation of hemangiopericytomas/
solid fibrous tumors (SFT)? Although preoperative embolizations of tumors are now commonly undertaken, as for
now, neither a clear statement nor a standardized approach has been given or developed. The purpose of this
article is to provide our experience with preoperative embolization and to start a new discussion concerning a
standardized approach.
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Hemangiopericytomas are tumors which derive from
Zimmerman’s pericytes. Stout provided the first report
and established the term hemangiopericytoma (HPC)
[1]. These are now reclassified as solid fibrous tumors.
A surgical therapy should involve a multimodal ap-
proach, as primary surgery can cause severe blood loss
in these highly vascularized tumors. Diagnostic tools
like biopsies should be conducted with great caution, if
HPCs are considered, as these tumors can lead to ex-
sanguination [2].
In 1976, Smith et al. described the first case of preopera-
tive embolization of retroperitoneal hemangiopericytomas
[3]. Although the resection was successfully undertaken,
after this experience, only a handful cases were described
which advocated a preoperative treatment prior to surgery.
Smullens et al. showed in their report of two patients that
a debulking of HPCs, especially concerning the massive
blood loss, can be eased using preoperative embolization* Correspondence: M.fard@asklepios.com
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(http://creativecommons.org/publicdomain/ze[4]. In 2000, Morandi et al. published a report of a patient,
who was diagnosed with a massive tumor in the mediasti-
num. Radiological finding suggested a resectable mass.
The patient underwent right thoracotomy, but massive
bleeding led to the abortion of the procedure and only a
biopsy was obtained. The patient lost 2.1 L of blood per-
operatively. Subsequently, an arterial embolization was
performed. Ten days later, the tumor was resected with
minimal blood loss. Therefore, the authors advocated a
preoperative embolization of highly vascularized HPCs
[5]. Another case of a lipomatous hemangiopericytoma,
described by Dozois et al., showed that preoperative
embolization, although as described in this case, not as
successful as desired, was crucial to perform the
debulking [6].
These cases show that in highly vascularized tumors,
especially in HPCs, preoperative arteographic imaging
and subsequent embolization, even if only performed
partly, reduce preoperative blood loss and increase the
chance to perform a radical resection.
The purpose of this article is to begin a new discus-
sion concerning the approach to highly vascularized tu-
mors, especially hemangiopericytomas. As to this date,article is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Fig. 2 Preoperative and postembolization CT showing
partial devascularization
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tioned aspects into account, does not exist.
Case presentation
A 70-year-old female patient was presented with lower
abdominal pain and constipation at our hospital. A com-
puted tomography (CT) was performed and revealed a
highly vascularized solid mass measuring 9 × 14 × 19 cm,
congestion of the kidneys, and compression of the rec-
tum (Fig 1). The highly vascularisation raised concerns
of high blood loss during surgery, and therefore, we
decided at our interdisciplinary tumor conference
(multidisciplinary team (MDT)) first, to perform a pre-
operative arterial embolization and resect the mass
subsequently.
An uneventful preoperative arterial embolization of the
superior and medial rectal arteries with coils and polyvinyl
alcohol particles was performed. The intervention was
done without any complications, and the patient re-
covered fast. Two weeks after the embolization, we ob-
tained a CT to assess the tumor, regarding size and
blood supply. As shown in Fig. 2, there was a partial
devascularization but unchanged size (Fig. 2). Figure 3
shows a digital subtraction angiography (DSA) with a
vascularization of the tumor prior to embolization and
Fig. 4 a DSA after the embolization with the coils
(Figs. 3 and 4)
Prior to the operation, transureteric stents were
placed. We took a standard fashioned transabdominal
approach to the abdomen. The large tumor wasFig. 1 Preoperative CT showing the size, vascularization, and location of thinfiltrating the rectum, ovaries uterus, and vagina. An
abdominoperineal extirpation was performed, and due
to the massive infiltration and expulsion, an intrale-
sional transection was done. After retrieving the tumor
and securing free margins, a permanent colostomy was
established (Fig. 5). The bladder was spared. The total
blood loss peroperatively was less than 200 cc.
The histological finding verified a HPC with a mitotic
index of 12 per 10 high-power field. Due to the highe tumor
Fig. 3 Digital subtraction angiography showing the vascularization of the tumor in the pelvis (arrows indicate the vasculature)
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toring with radiographic assessment. The patient recovered
quickly from surgery. A delay of the discharge was due to
an uncomplicated wound healing disturbance.
Radiological assessment after 17 months revealed a
hepatic mass in segment 7 (8 cm) and a mass at the
roof of the bladder (3 cm) as a sign of local recurrence.
Figure 6 shows an axial CT before the operation and
Fig. 7 the coronar plane of the CT (Figs. 6 and 7).
Therefore, we discussed the case in the MDT and pro-
posed a hepatic resection and local resection without
prior embolization. Intraoperatively, the mass was con-
firmed by ultrasound, and an anatomical resection of
segment 7 and partial resection of the bladder was per-
formed. The blood loss was minimal, and the postopera-
tive course was uneventful. The patient was discharged
after 7 days. Histology revealed the solid fibrous tumor
with a mitotic index of 11 per high-power field. After the
second operation, the patient is without any recurrence
after 13 months.Conclusions
Hemangiopericytomas are highly vascularized large tu-
mors, which arise from pericytes, and are found more
commonly in the abdomen or pelvis [7–12]. There are
cases which describe tumors in the mediastinum,
esophagus, and femur. Even peritoneal carcinomatosis
has been seen [5, 13–15]. The symptoms vary from
bleeding, extrusion, or pain [16, 17]. HPCs, especially
those located in the abdomen, can be as aggressive as
angiosarcomas, and metastasis to the bone and lung has
also reported [13, 18]. As described before, the potential
life threatening blood loss poses a difficult issue for the
surgeon. Complete resections of these tumors are often
limited due to the fact that viable structures are affected.
We believe that preoperative angiographic imaging
and subsequent embolization are crucial to guarantee
complete resection and concomitantly reduce pero-
perative morbidity and mortality. The possibility to
achieve a complete debulking with free margins can be
reached with this approach. In 2012, Asano et al.
Fig. 4 Digital subtraction angiography after the embolization (arrows indicate the coils)
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of a large HPC an embolization was performed with a
good outcome [19].
Do we change the rate of recurrent disease if we per-
form a transection of these large tumors, as done in this
case? Although, data presented by Espat et al. in 2002
showed with a collective consisting of 25 patients with a
follow-up of 49 months metastases in 20 % and local re-
currence in 4 % of the resected patients, interestingly,
our patient did recur locally and distantly [20]. An effectFig. 5 Specimen ex-situof the transection cannot be proven, but one must be
cautious if transection is performed. The postoperative
course after the second operation was uneventful and
blood loss minimal. One may ask, why we did not per-
form embolization of the tumors before the secondFig. 6 Preoperative CT before the second operation, showing the
hepatic mass in segment 7 in the axial plane
Fig. 7 Preoperative CT before the second operation, showing the hepatic mass in segment 7 in the coronar plane
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easily accessible and bulky tumors of the pelvis (like in this
case) in liver surgery vascular control is mandatory and in-
herently part of hepatic resection. Certainly, also the size
and the location of the tumor in the liver are vital for the
decision to perform transarterial embolization. The size
and the location of the hepatic metastases in this case
were favorable (Fig. 6). Additionally, the size of the local
recurrence was only 3 cm and easily accessible.
In 2015, Manatakis et al. described a case of hepatic me-
tastases of a HPC. In their final statement, they proposed
transarterial embolization due to the “hypervascularity of
the tumor”. If the case is read carefully, the authorsTable 1 List of recently published case reports with HPCs in the abd
Author Year Localization Embolizatio
Manatakis et al. 2015 Liver (metb) No
Vetorazzo et al. 2015 Kidney (pria) No
Hu et al. [24] 2014 Kidney (pri) No
Bokshan et al. 2012 Liver (met) No
Asano et al. 2012 Pelivs (pri) Yes
Katsuno et al.[25] 2011 Pelvis (pri) No
Follow-up indicates time of recurrent-free-survival
aPrimary
bMetastasisdescribe a first liver resection without (!) embolization
with an uneventful course and state that before the second
liver resection, the transarterial embolization was used as
tool to “bridge” [21]. Also in 2015, Vetorazzo et al. de-
scribed a case of a renal HPC without prior embolization
with an uneventful resection [22].
Bokshan et al. showed that even larger resections
could be safely performed if in the hands of a dedicated
center. In 2012, they published a case of a hepatic me-
tastasized HPC and an ex vivo resection with veno-
venous bypass, and reconstruction of the left liver vein
with replacement of the inferior vena cava was per-
formed without mortality [23].omen
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scribing HPCs of the abdomen (Table 1)
Due to the low-incidence of HPCs in the abdomen, a
clear statement regarding a preoperative embolization
(which localization? which size? or what timing?) cannot
be given. We propose following approach for tumors af-
fecting visceral organs in the abdominal cavity:
If the tumor is located in the abdominal cavity/pelvis
and is large (a clear value cannot be given but large in
the sense of infiltrating or displacing other organs), an
embolization needs to be performed. On the other hand,
if the location and the size of the tumor are favorable, a
hepatic resection can be performed straightaway.
Certainly, the most crucial part of the treatment is a
thorough discussion in the MDT.
In our opinion, preoperative embolization should be
incorporated into this interdisciplinary approach.
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